Genomic profiling of pediatric cancer may expand treatment options for patients experiencing a relapse

Genomic sequencing of tumors from pediatric cancer patients experiencing a relapse enabled 107 patients to receive an appropriate matched therapy that is not the standard of care, according to data from the international clinical trial MAPPYACTS, published in Cancer Discovery, a journal of the American Association for Cancer Research.

source https://medicalxpress.com/news/2022-03-genomic-profiling-pediatric-cancer-treatment.html